Further shaping the Life Innovation Business (LIB)
At the end of 2019, the Yokogawa Life Innovation Business (LIB) reported on recent market strategies, product developments, and plans.…
Further shaping the Life Innovation Business (LIB) Read More »
At the end of 2019, the Yokogawa Life Innovation Business (LIB) reported on recent market strategies, product developments, and plans.…
Further shaping the Life Innovation Business (LIB) Read More »
Read our interview with Prisca Liberali, Junior Group Leader at Friedrich Miescher Institute for Biomedical Research in Basel (Switzerland). At…
When a person thinks about Life Science usually topics like drug development, cancer research, genetic as well as 3D tissue…
In order to drive the Yokogawa Life Innovation Business (LIB) forward in Europe, Dr. Gerd Heimlich joined Yokogawa as a…
The Yokogawa Life Innovation Business is on the move Read More »
Biotechnology enables the generation of highly complex active ingredients that are used in the treatment of, for example, diabetes. Read…